EGFR and neoplasm: Most importantly, activation of autophagy can induce either cancer cell chemoresistance (when initiated via EGFR signaling for example) or autophagic cell death (e.g., when initiated by β-catenin, AKT or Ras signaling), depending on the tumor type and treatment.